These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 29705708

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Design and synthesis of potent and selective aldose reductase inhibitors based on pyridylthiadiazine scaffold.
    Chen X, Yang Y, Ma B, Zhang S, He M, Gui D, Hussain S, Jing C, Zhu C, Yu Q, Liu Y.
    Eur J Med Chem; 2011 May; 46(5):1536-44. PubMed ID: 21367494
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and biological evaluation of steroidal derivatives as selective inhibitors of AKR1B10.
    Zhang W, Wang L, Zhang L, Chen W, Chen X, Xie M, Yan G, Hu X, Xu J, Zhang J.
    Steroids; 2014 Aug; 86():39-44. PubMed ID: 24793566
    [Abstract] [Full Text] [Related]

  • 6. Structural Determinants of the Selectivity of 3-Benzyluracil-1-acetic Acids toward Human Enzymes Aldose Reductase and AKR1B10.
    Ruiz FX, Cousido-Siah A, Porté S, Domínguez M, Crespo I, Rechlin C, Mitschler A, de Lera ÁR, Martín MJ, de la Fuente JÁ, Klebe G, Parés X, Farrés J, Podjarny A.
    ChemMedChem; 2015 Dec; 10(12):1989-2003. PubMed ID: 26549844
    [Abstract] [Full Text] [Related]

  • 7. Design, synthesis, in vitro and in silico investigation of aldose reductase inhibitory effects of new thiazole-based compounds.
    Sever B, Altıntop MD, Demir Y, Akalın Çiftçi G, Beydemir Ş, Özdemir A.
    Bioorg Chem; 2020 Sep; 102():104110. PubMed ID: 32739480
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Design and synthesis of potent and multifunctional aldose reductase inhibitors based on quinoxalinones.
    Qin X, Hao X, Han H, Zhu S, Yang Y, Wu B, Hussain S, Parveen S, Jing C, Ma B, Zhu C.
    J Med Chem; 2015 Feb 12; 58(3):1254-67. PubMed ID: 25602762
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inhibitor selectivity between aldo-keto reductase superfamily members AKR1B10 and AKR1B1: role of Trp112 (Trp111).
    Zhang L, Zhang H, Zhao Y, Li Z, Chen S, Zhai J, Chen Y, Xie W, Wang Z, Li Q, Zheng X, Hu X.
    FEBS Lett; 2013 Nov 15; 587(22):3681-6. PubMed ID: 24100137
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Novel quinazolinone-based 2,4-thiazolidinedione-3-acetic acid derivatives as potent aldose reductase inhibitors.
    Metwally K, Pratsinis H, Kletsas D, Quattrini L, Coviello V, Motta C, El-Rashedy AA, Soliman ME.
    Future Med Chem; 2017 Dec 15; 9(18):2147-2166. PubMed ID: 29098865
    [Abstract] [Full Text] [Related]

  • 17. Design and synthesis of novel quinazolin-4(1H)-one derivatives as potent and selective inhibitors targeting AKR1B1.
    Han Z, Li J, Xu Z, Su Y, Wang Y, Zhuo L, Du J, Zhu C, Hao X.
    Arch Pharm (Weinheim); 2023 Apr 15; 356(4):e2200577. PubMed ID: 36707406
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.